Home › Familial Amyloid Neuropathies › North Carolina
Familial Amyloid Neuropathies clinical trials in North Carolina
4 studies for Familial Amyloid Neuropathies are looking for participants at sites in North Carolina.
Cities in North Carolina
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Durham
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Durham
RecruitingObservational study
All ages · All sexes · Updated Sep 8, 2026 · NCT04561518Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
- Sanger Heart and Vascular Institute, Charlotte
Recruiting
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT06096675From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.